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Abstract: 
Introduction: Image guided surgery has become standard practice during surgical resection, using preoperative 
MRI. Intraoperative-ultrasound has attracted interest, because of its perceived safety, portability, and real-time 
imaging. This is a meta-analysis of intraoperative-ultrasound in gliomas.  
Methods: Critical literature review and meta-analyses, using MEDLINE/PubMed service. The list of references 
in each article was double-checked for any missing references. We included all studies that reported the use of 
ultrasound to guide glioma-surgery. The meta-analyses were conducted according to statistical heterogeneity 
between the studies using Open MetaAnalyst Software. If there was no heterogeneity, fixed effects model was 
used for meta-analysis; otherwise, a random effect model was used. Statistical heterogeneity was explored by χ2 
and inconsistency (I2) statistics; an I2 value of 50 percent or more represented substantial heterogeneity. 
Results: Casting a wide-net search caught 19,109 studies that might be relevant, of which 4,819 were 
ultrasound in neurosurgery. 756 used ultrasound in cranial surgery, of which 24 studies used intraoperative 
ultrasound to guide surgical resection and 74 to guide biopsy. Fifteen studies fulfilled our stringent inclusion 
criteria, giving a total of 739 patients. The estimated average gross total resection rate was 77%. Furthermore, 
the relationship between extent of surgical resection and study population was not linear. GTR was more likely 
under IoUS when the lesion was solitary, subcortical, and no past history of surgery or radiotherapy. IoUS 
image quality, sensitivity, and specificity, positive & negative predictive values deteriorated as surgical 
resection proceeded.    
Conclusion: IoUS guided surgical resection of gliomas is a useful tool for guiding the resection and of value in improving 
the extent of resection. IoUS can be used in conjunction with other complementary technologies that can improve 
anatomical orientation during surgery. Real-time imaging, improved image quality, small probe sizes, repeatability, 
portability, and relatively low cost made IoUS a realistic cost effective tool that complements any existing tools in any 
neurosurgical operating environment.  
Keywords: Glioma, Image guided surgery, neuronavigation, Intraoperative ultrasound.  
Introduction: 
Gliomas are the commonest primary brain tumours and their prognosis is dependent upon the grade of glioma 1. 
Maximum safe surgical resection, when possible, has been accepted as the primary therapy in most cases and 
the extent of surgical resection has been established as an independent prognostic factor.  Following gross total 
resection (GTR) the 5 and 10 year survival rates for low-grade gliomas (LGG) have improved to 97% and 91% 
respectively 2. However, the prognosis of high-grade gliomas (HGG), though have improved significantly in 
recent years, remains bleak with a median survival of merely 16 months 3. To achieve maximum safe surgical 
resection, image guided surgery (IGS) has been deployed in the last three decades and advances in 
neuroimaging, stereotaxy, and computer technology, have permitted neurosurgeons to plan and execute surgical 
approaches with greater accuracy and precision. 
Several technologies have been developed to aid neurosurgeons to plan and execute maximum safe surgical 
resection of gliomas. In the forefront of these techniques the use of image guided surgery (IGS), Intraoperative 
MRI (IoMRI), Intraoperative Ultrasound (IoUS), and Fluorescence image guided surgery (FIGS). The biggest 
drawback of IGS is its dependence on preoperatively acquired images to navigate during surgery. Brain shift 
that occurs when the dura is opened due to CSF drainage, tissue removal, and gravity introduces significant 
inaccuracies that render IGS useless intra-operatively. Furthermore, without further imaging there is no way of 
real-time feedback about the extent of surgical resection. Hence, IoMRI, FIGS and IoUS were introduced. 
IoMRI restricts the environment of surgery because of ferromagnetic interference, interruption of the workflow 
each time an MRI is performed and its expensive upkeep. FIGS, using 5-aminolevulinic acid (ALA) induced 
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fluorescence, is cost effective in HGG. However, it cannot be used in LGG surgery where it is most needed 4. 
IoUS was put forward as a complementary technology to overcome some of the aforementioned limitations of 
IGS. Therefore, we reviewed the literature to realize the benefits and constraints of IoUS during surgical 
resection. 
Materials and Methods:  
The medical literature was searched extensively, beginning with basic searches of the MEDLINE/PubMed 
service of the US National Library of Medicine, using the MeSH (medical subject heading) terms “ultrasound,” 
“image guidance,” “glioma,” “brain,” “high grade glioma,” “low grade glioma” “neurosurgery,” and “surgery” 
in various combinations. Furthermore, Web of Knowledge database, BIOSIS Previews, Cochrane library, and 
Web of Science were searched. 
 
Each article of interest was screened and its reference list was double checked to make sure that no relevant 
article was missed. The Internet itself was searched for leads to articles appearing in journals not indexed in 
these databases. We restricted the literature review to the last 10 years (2005 to 2015) based on SIGN (Scottish 
Intercollegiate Guidelines Network) review criteria 5. Studies with information about diagnosis, intended extent 
of resection and postoperative evaluation of extent of resection by neuroimaging were considered. We included 
all studies that fulfilled the following inclusion criteria: glioma surgical resection, IoUS was used as a guidance 
tool, study population was 10 patients or more, and assessment of the extent of surgical resection was 
confirmed by postoperative imaging. Studies that reported mixed series of patients were included as long as the 
number of glioma patients in the series was ten or more and we included data for the glioma patients only. We 
excluded studies that were not in English, duplicate publications or failed one or more of our inclusion criteria. 
The remaining studies were assessed objectively against SIGN criteria 5.  
The meta-analyses were conducted according to statistical heterogeneity between the studies using Open 
MetaAnalyst Software version 0.1 for Mac. If there was no heterogeneity, fixed effects model was used for 
meta-analysis; otherwise, a random effect model was used. Statistical heterogeneity was explored by χ2 and 
inconsistency (I2) statistics; an I2 value of 50 percent or more represented substantial heterogeneity. 
Furthermore, GTR rate was analysed to determine the success of the surgery, and to ascertain the reliability of 
the results and determine whether the number of patients involved in each study was related to the overall GTR 
rate, a correlation coefficient was calculated. The average GTR rate and correlation coefficient were calculated 
using Microsoft Excel 2010.  
 
Results: 
The initial wide-net search produced a total of 19,109 publications dealing with surgical ultrasound (Figure 1). 
Restricting the search to neurosurgical applications reduced the number of publications to 4,819 studies. The 
main focus of 4,063 publications was on extracranial applications and the remaining 756 focused on cranial 
applications, of which 98 were dedicated to IoUS guided glioma surgery. IoUS was used to guide biopsy in 74 
studies and to guide surgical resection in twenty-four studies. These 24 publications were reviewed critically 
against our inclusion criteria. Only fifteen studies fulfilled our inclusion criteria. Table 16-12 details the reasons 
of exclusions of nine studies and Table 213-27 details summaries of the included fifteen studies in this meta-
analysis.  
Insert Figure 1 and Tables 1 & 2 here 
IoUS and gross total resection (GTR): 
The GTR was defined as the absence of any residual enhancement on postoperative volumetric enhanced MRI 
performed within 72 hours of the surgical resection. The total number of patients included in this review was 
739 patients. The meta-analyses demonstrated an estimated average GTR rate of 77% (95% CI was 67.1 to 
86.9). The studies by their nature were very heterogeneous (I2 = 92.598, p <0.001) (Figure 2).  The correlation 
coefficient between GTR rate and study population was -0.2464, which indicated non-linear relationship, 
suggesting that GTR rate was not greatly improved by increasing the number of operations. Postoperative MRI 
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in all included studies was used to assess the extent of surgical resection; the concordance rate between IoUS 
and postoperative MRI was 82%, the false positive rate of IoUS was 9% and the false negative rate was also 
9%.  
Insert Figure 2 here 
There were differences in the GTR rates of IoUS in HGG and LGG; enough details of HGG was reported in six 
studies with an estimated average GTR rate of 71.9%  (95% CI was 64-79.7). Heterogeneity in these studies 
was not statistically significant (I2 = 49.778, p 0.052) (Figure 3A). The GTR rate was 88% in resectable lesions; 
single supratentorial in non-eloquent brain.  The GTR rate in LGG was reported less frequently (three studies); 
the estimated average GTR rate in LGG was 78.1% (95%CI 67.1-89.1). These studies were not heterogeneous  
(I2 = 0, p 0.380) (Figure 3B). Furthermore, in 59% of procedures, IoUS prompted surgeons to remove residual 
tumour tissue from the resection cavity. 
Insert Figures 3A & 3B here. 
IoUS and lesion-localization, sensitivity & specificity: 
Six studies reported the percentage of procedures, where IoUS was successful in identifying the exact location 
of the intradural lesion after craniotomy; the mean localization rate in these studies was 100%. However, image 
quality was considered poor in 8% of procedures. The sensitivity of IoUS was defined as the number of times 
IoUS identified residual tumour tissue and subsequent resection and histopathology confirmed the tissue was in 
fact tumour. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 
IoUS were best before the start of surgical resection (95%, 95%, 98%, and 90% respectively). All four values 
deteriorated as surgery proceeded; a sensitivity of 88%, specificity of 42%, PPV of 73% and NPV of 67% 
during surgery was reported and at the end of surgery the corresponding values were 26%, 88%, 62%, and 62% 
respectively.  
Clinical outcome of patients, who underwent surgery under IoUS guidance: 
Survival data was not reported in most of the studies included in our analyses, and when reported other 
confounding factors played a significant role such as; patient selection, small sample size, lack of controls, and 
varied adjuvant therapies. One study reported a 6-month survival of LGG matched controls (IoUS was not 
used) as 96.7%, the 1-year survival was 73.3%; and 2-year survival was 53.3%. In the study LGG-group, where 
IoUS was used to navigate and guide surgical resection, survival rates at 6 months, 1-year, and 2-years were 
98.0%, 96.1%, and 88.2%, respectively. In the same study the control and study HGG-groups, survival rates at 
6 months, 1-year, and 2-years were 83.3% versus 93.4%, 43.3% versus 59.2%, and 13.3% versus 32.8% 
respectively. There was no significant difference in survival rates between study and control groups at 6-months  
(p >0.05). However, the 1-year, and 2-years survival rates of the study groups of LGG and HGG, where IoUS 
was used, were significantly better than the survival rates of the controls (P  < 0.05). Worsening neurological 
status in patients, where IoUS was used, was reported in 11.3% (8% to 13%). The majority of patients were 
unchanged neurological postoperatively and 19% were better off. 
Type of IoUS used: 
Most studies used 3D mode IoUS such as the SonoWand® (SonoWand, Mison,Trondheim, Norway), equipped 
with a 5 MHz probe with tracking, which can be used in 2D mode in conjunction with preoperative MRI-based 
IGS system14,15,21,23. Other systems used included high-frequency (5-10 MHz) ultrasound probes with a 180 
Plus system (SonoSite, Inc, Bothell, WA)18, an SSD-alpha10 system (Aloka Co, ltd, Tokyo, Japan), Seimens 
Omnia Sonoline and Capasee II (Toshiba, Japan)19. 3D IoUS mode was used in 7 studies, and 2D mode in the 
rest. The estimated average GTR rate using 2D IoUS was 84.3% compared to 70.9% using the 3D navigated 
IoUS, the difference was not statically significant (p 0.699). 
Discussion:  
 
Ultrasound imaging has been available for years before CT and MRI. However, its use in cranial imaging was 
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hindered by the rigid bony structure of the skull that impedes ultrasound waves. This limitation is no longer an 
issue after the craniotomy, and the main limitations during cranial surgery were ultrasound probe-size, which 
was too big for the size of craniotomy and image quality, which was poor compared to CT or MRI images. In 
recent decades the quality of ultrasound imaging improved significantly with 3D acquisition and sophisticated 
computer technology, and the ultrasound probe-size became more user friendly in craniotomies6-27. 
Furthermore, the extent surgical resection in low-grade gliomas (LGG) and high-grade gliomas (HGG) have 
been shown to be an independent prognostic factor for progress free survival (PFS) and overall survival (OS)27-
37
. Therefore, the aim of surgical treatment of gliomas is to achieve safe maximum surgical resection whenever 
possible and preserve normal function and good quality of life. However, maximum safe surgical resection 
remains a challenge because gliomas are locally invasive and tumour cells infiltrate beyond the normal apparent 
tumour margins. Improvements in Ultrasound technology and accumulating evidence in support of maximum 
safe surgical resection of gliomas ignited new interest in IoUS, to overcome the limitations of IGS. IoUS was 
used in conjunction with IGS to correct errors introduced by brain shift. Brain shift varied from 2 mm to 25 mm 
depending upon the location and size of lesion24. The main advance in IoUS technology was the development 
of small ultrasound probes for superficial lesions (7.5-10 MHz) and for deep lesions (3-5 MHz)19. An excellent 
example of integration of IGS and IoUS technologies is the SonoWand®. The SonoWand® system can be used 
as an IGS system based on preoperative MRI images and for 2D or 3D IoUS imaging. Real-time 2D IoUS 
imaging can be performed as with a conventional ultrasound scanner, but with the optional feature of 
comparison with corresponding slices of preoperative 3D MRI imported into the SonoWand® system. The 
integration of ultrasound imaging and IGS-navigation technology enabled acquisition of 3D ultrasound 
volumes, typically generated from 200 to 300 image slices. The ultrasound image volumes can be readily 
acquired when needed during surgery, and the data are displayed with preoperative MRI data on the navigation 
monitor when using tracked tools such as a pointer or ultrasound aspirator. 3D navigation may offer easier 
anatomical orientation due to displays of images in an orthogonal (patient-related slices) or reformatted 
according to the position of the tracked tool (tool-related slices). The SonoWand® comes with two flat-phased 
arrays (FPA) ultrasound probes, one FPA 5 (4–7 MHz) and a smaller FPA 10 (5–10 MHz) probe. The newer 
system (SonoWand® Invite) comes with a third larger FLA (5–14 MHz) probe21. A random effect model was 
used in our study because of heterogeneity (I2 > 50%, p<0.05)), and the estimated overall GTR rate was 77% using 
IoUS. The estimated average GTR rate of HGG was 71.9% compared to GTR rate of 78.1% in LGG 
(Heterogeneity was not significant in the HGG and LGG data sets, I2 < 50% , p >0.05). Image quality and the 
operators’ learning curves played an important role in IoUS GTR rates. One study reported IoUS image quality 
was good enough to delineate the margins of HGG in 83% of cases and poor IoUS image quality was more 
likely in patients with previous surgery (p-=0.002) or in patients who had previous radiotherapy (p=0.001) 21.  
Patient selection therefore played a significant role in the outcome of GTR in these studies, for example the 
GTR in patients, with single supratentorial enhancing lesions that did not invade the basal ganglia or corpus 
callosum and had a preoperative Karnofsky performance score of 70 or better, was 2.5 times better than that of 
the whole group21. The predictors of GTR were explored in a multivariate analysis model and four significant 
prognostic factors were found; aim of surgery was GTR (p <0.001), single lesion (p=0.003), good or medium 
quality IoUS images (p=0.026), and non-eloquent lesion-location (p=0.015). Other factors, which were 
significant on univariate analysis that dropped out in the multivariate model, included small lesion volume, 
Karnofsky performance of 70 or better, no prior radiotherapy, primary surgery, and no extension into the basal 
ganglia or the corpus callosum21.  Furthermore, the quality and resolution of IoUS images decreased as the 
surgical resection proceeded because of artefacts introduced by surgical manipulation22. With experience, 
strategies have been developed to overcome the majority of these problems38. A much bigger problem with 
IoUS was getting familiar with anatomical orientation. Traditionally B-mode ultrasound displayed 2D 
ultrasound images in a planar format dependent on the ultrasound probe used with the view limited to the sector 
of sonication, which is often oblique rather than axial. Anatomical disorientation was amplified by lack of 
easily identifiable brain-landmarks within small exposures. However, real-time IoUS imaging during surgery, 
3D IoUS and precalibration and integration of IoUS with IGS improved anatomical orientation4,13-27. 
Furthermore, specialised motorised IoUS probes or reconstruction of 2D IoUS images acquired by tracked 
probes produced good quality 3D images improving anatomical orientation during surgery5,39-43.  Without good 
quality intraoperative imaging surgeons often over-estimated the extent of surgical resection. In one study using 
3D IoUS feedback, surgeons esimtated the extent of surgical resection correctly in 59%. The main reasons of 
over-estimates were poor intraoperative image quality21.   The sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV) of IoUS were best before the start of surgical resection (95%, 95%, 
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98%, and 90% respectively). All four values deteriorated as surgery proceeded; a sensitivity of 88%, specificity 
of 42%, PPV of 73% and NPV of 67% during surgery was reported and at the end of surgery these figures were 
26%, 88%, 62%, and 62% respectively23. In our meta-analyses, the estimated the average GTR rates of  HGG 
and LGG were 71.9% and 78.1% respectively, which were comparable to the reported GTR rates using other 
neuronavigation technologies. A retrospective study compared IGS with standard surgical resection in HGG 
reported a GTR rate of 64% in the neuronavigation group compared to 38% in the standard surgery group44.  
On the other hand a randomised controlled study reported a GTR rate of 31% using IGS in glioblastoma (GBM) 
compared to 19% with standard surgery45.  A multicentre randomised controlled study comparing FIGS with 
standard IGS in HGG reported 64% GTR rate in the FIGS group compared to 36% in the IGS group. A meta-
analysis of FIGS, using ALA- induced fluorescence, in 565 GBM-resections reported a GTR rate of 75.4% 
(95% CI 67.4-83.5)47, which is comparable to the findings of this meta-analysis of IoUS. IoMRI using low field 
and high field magnets have been in use for some time, the results of IoMRI in gliomas varied considerably; 
GTR rates of 31% using 1.5T system48, 67% using 0.2T system49, and 71% using 0.15T system50 were reported. 
These varied results were unlikely to be related to the strength of the IoMRI but more likely due to patient 
selection. One small study compared 2D navigated IoUS to low field IoMRI in 26 patients reported IoMRI was 
superior51.  Another study compared high field IoMRI and linear array IoUS in 44 grade II astrocytoma biopsies 
to evaluate their accuracy and found imaging results of linear-array IoUS significantly correlated to high field 
IoMRI images (Spearman's Rho p < 0.009), the specificity of both modalities was 67%, and the sensitivity of 
IoMRI was higher than IoUS (83% versus 79% respectively)52. Another randomised study of GTR between 
IGS and IoUS was used to compare GTR of 95% or more in 93 HGG; the IoUS sensitivity and specificity were 
higher than IGS alone, the sensitivity of IoUS was superior in newly diagnosed HGG compared to recurrent 
HGG, and there was no significant difference in the GTR rates between IoU  and IGS53.  One of the major 
limitations of IoUS was that it cannot assist in the size or location of the skull opening and hence it is best used 
in conjunction with other IGS technologies. Once the craniotomy was performed, IoUS was very useful in 
planning and executing the dural opening, the cortical incision, and identifying surrounding critical structures29.   
HGG Forty % of lesions were clearly identifiable with clear margins on ultrasonography,  
Furthermore, in 59% of cases where IoUS imaging was performed to guide the extent of surgical resection, 
IoUS prompted more tumour resection15. However, not all gliomas are suitable for GTR, for example in the 
same study 21% of cases IoUS demonstrated residual HGG and the surgeon decided to stop the resection 
because of tumour- proximity or invasion of eloquent brain tissue.   
The accepted GTR-definition is the absence of residual enhancement in the resection cavity on postoperative 
enhanced 3D MRI images obtained within 72 hours of surgery46. However, from clinical perspective a resection 
of more than 98% of the enhancing lesion imparts the best survival outcome in HGG1. It is also accepted that 
enhanced MRI scan and almost all imaging modalities do not delineate the full extent of HGG. For example a 
study compering MRI with ultrasound images in HGG demonstrated agreement between the two modalities in 
only 40% of lesions with lesions in average 18.9% larger in MRI images54.  Furthermore, a comparison of FIGS 
and MRI demonstrated that enhanced 3D MRI images underestimated the size of HGG55.  
Survival data of gliomas undergoing surgery using 3D-IoUS navigation could not be attributed to the surgical 
technique alone, as tumour grade, location, preoperative performance status, age, and the extent of surgical 
resection play a significant role. The 6-month survival of LGG matched controls, where IoUS was not used, 
was 96.7%, the 1-year survival was 73.3%; and the 2-year survival was 53.3%. In the same study LGG-group, 
where IoUS was used to navigate and guide surgical resection, survival rates at 6 months, 1-year, and 2-years 
were 98.0%, 96.1%, and 88.2%, respectively. In the same study the control and study HGG-groups, survival 
rates at 6 months, 1-year, and 2-years were 83.3% and 93.4%, 43.3% and 59.2%, and 13.3% and 32.8%. When 
comparing survival rates at 6-months, 1-year, and 2-years between the control and study groups, there were no 
significant difference at 6-months (P  > 0.05), but survivals at 1- and 2-years were significantly different (P  < 
0.05), with those undergoing surgery with 3D navigated IoUS faired better18. The overall neurological 
functional outcome in patients undergoing GTR using IoUS was reported as; 8%- 13% worse, 19% better and 
the rest were unchanged from preoperatively14,21; the risk factors for bad outcomes were previous surgery or 
previous radiotherapy (8% in primary surgery versus 22% in reoperations)21. However, worsening neurological 
function could not be attributed entirely to the use of IoUS as similar incidence of side effects were reported 
with standard surgery, IGS, or FIGS alone. Although, scientists, economists, and healthcare policy makers 
would like to see prospective studies comparing IoUS with IoMRI, FIGS and IGS, these studies are difficult to 
undertake because these technologies are complementary to each other and often used in combination. 
Our meta-analysis is as good as the underling studies upon which it was based, however, a key benefit of meta-
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analyses is the aggregation of information leading to a higher statistical power and more robust point estimate 
than is possible from the measure derived from any individual study on its own.  The limitations of the selected 
studies included; some studies had small sample sizes with less than 20 patients, short follow up, lack of 
controls and detailed outcome assessments, and varied adjuvant therapies, IoUS imaging lacked full-head 
display making anatomical orientation more tricky without the complement of IGS, the 3D IoUS images were 
not in real-time, image quality may have deteriorated due to surgical-field movement, surgical manipulation, 
surgical-cavity collapse, and tissue trauma, and IoUS interpretation by enlarge was operator dependent.  
Conclusion: IoUS guided surgical resection of gliomas is a useful tool for guiding the resection and of value in 
improving the extent of resection. IoUS can be used in conjunction with other complementary technologies that 
can improve anatomical orientation during surgery. Real-time imaging, improved image quality, small probe 
sizes, repeatability, portability, and relatively low cost made IoUS a realistic cost effective tool that 
complements any existing tools in any neurosurgical operating environment.   
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Figure legends: 
Figure 1: Flow chart of the literature search of IoUS in glioma surgery. 
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Figure 2: Forest plot demonstrating meta-analysis model with all fifteen studies included, with GTR rate of 
77% (95%CI 67.1%- 86.9%), Heterogeneity was significant (I2 >50, p <0.05). 
Figure 3: Forest plot demonstrating meta-analysis model; A= in HGG, GTR 71.9% (95%CI 64%- 79.9%), 
Heterogeneity was not significant (I2 <50, p >0.05), B= in LGG, GTR 78.1% (95%CI 67.1%- 89.1%), 
Heterogeneity was not significant (I2 <50, p >0.05) . 
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Table 1:  Excluded Studies: 
 
Author Year of Publication Reason for exclusion 
Chacko AG et al 6 2003 Less than 10 gliomas 
Gulati S et al 7 2009 Incomplete data. 
Enchav Y et al 8 2006 Incomplete data.  
Steno A et al 9 2012 Less than 10 gliomas 
Wang YQ et al 10 2012 Technical report. 
Saether CA et al 11 2012 Incomplete data. 
Erdogan N et al 12 2005 Incomplete data. 
Two more studies were excluded because they were technical in nature. 
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Table 2: Studies that fulfilled the inclusion criteria: 
 
Reference Total GTR % Estimates Reported details of IoUS in each series 
Mean Lower Upper Location HGG* LGG* Sen% Sp% SuD% 
Coburger J et al13  15 73.3 51 95.7        
Moiyadi A et al 14 67 82.2 73.9 90.4 100% 47%    59 
Liang SQ et al 15 80 86.2 79.4 92.9 100%      
Peredo-Harvey et al 16 18 85.6 79.7 91.6       
Serra C et al 17 14 86.9 81.7 92       
Wang J et al 18 137 81.8 73  90.6 100% 67.2% 70.6%    
Moiyadi A et al 19 41 82 71.6 89.5 100%      
Rohde V et al 20 16 80.7 73.3 88.1    71 60  
Solheim O et al 21 142 74.5 60.6 88.5  37%     
Tian YJ et al 22 88 76.7 63.8 89.6    80.1 69.8  
Rygh OM et al 23 19 76.9 64.8 89.1    95 95  
Lindner D et al 24 23 77 65.6 88.5 100%      
Zhao P et al 25 35 78.2 67.7 88.8 100%      
Renner C et al 26 22 76.2 65.7 86.6  76.2%     
Unsgard G et al 27 22 76.6 66.6 86.5       
Overall results of model 739 77 67.1 86.9 100 56.8 70.6 82 74.9 59 
 
IoUS= Intraoperative ultrasound, HGG=high grade glioma, LGG=low grade glioma, * values are GTR %, Sen%=sensitivity %, 
Sp%=specificity %, SuD%=% of procedures where IoUS had changed the surgical decision or led to further resection. 
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List of abbreviations: 
 
ALA= 5-aminolevulinic acid. 
AVM= areteriovenous malformation. 
CSF= cerebrospinal fluid. 
FIGS= fluorescence imaged guided surgery. 
GTR= gross total resection. 
HGG= high grade gliomas. 
IGS= image guided surgery. 
IoUS = intropertaive ultrasound. 
IoMRI= intraoperative magnetic resonance imaging. 
LGG= low grade gliomas. 
MRI= magnetic resonance imaging. 
OS= overall survival. 
PFS= progression free survival. 
PpIX= protoporphyrin IX. 
SIGN= Scottish Intercollegiate guidelines network. 
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Highlights: 
• Maximum safe surgical resection is the aim of glioma surgery. 
• The extent of surgical resection of gliomas affects the prognosis. 
• Image guided surgery including intraoperative MRI, fluorescence and 
ultrasound are used to enhance the resection. 
• Intraoperative ultrasound is safe, reliable and offers high gross total 
resection rate. 
